New sensitive one-step real-time duplex PCR method for group A and B HIV-2 RNA load

Journal of Clinical Microbiology

Volumn 52, Issue 8, 2014, Pages 3017-3022

  Avettand Fenoel, Véronique ^a,b   Damond, Florence ^b,c,d   Gueudin, Marie ^e,f   Matheron, Sophie ^b,c,d   Mélard, Adeline ^b   Collin, Gilles ^b,c,d   Descamps, Diane ^b,c,d   Chaix, Marie Laure ^g   Rouzioux, Christine ^a,b   Plantier, Jean Christophe ^e,f  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITÉ PARIS DIDEROT   (France)

^d BICHAT HOSPITAL   (France)

^e HÔPITAL CHARLES NICOLLE   (France)

^f UNIVERSITÉ DE ROUEN   (France)

^g SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ARTICLE; BIOLOGICAL MONITORING; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EPIDEMIC; GENETIC ANALYZER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; INTERMETHOD COMPARISON; LABORATORY AUTOMATION; LONG TERMINAL REPEAT; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION SYSTEM; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STRUCTURAL GENE; VALIDATION PROCESS; VIRUS DETECTION; VIRUS LOAD; COMPARATIVE STUDY; EVALUATION STUDY; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; MULTIPLEX POLYMERASE CHAIN REACTION; PROCEDURES; REPRODUCIBILITY; VIROLOGY;

HIV INFECTIONS; HIV-2; HUMANS; MULTIPLEX POLYMERASE CHAIN REACTION; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 84905253297     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00724-14     Document Type: Article

References (31)

1. Andreasson PA, Dias F, Naucler A, Andersson S, Biberfeld G. 1993. A prospective study of vertical transmission of HIV-2 in Bissau, Guinea-Bissau. AIDS. 7: 989-993. http://dx.doi.org/10.1097/00002030-199307000-00013. (Pubitemid 23239674)
2. Kanki PJ, Travers KU, MBoup S, Hsieh CC, Marlink RG, Gueye-NDiaye A, Siby T, Thior I, Hernandez-Avila M, Sankale JL, Ndoye I, Essex ME. 1994. Slower heterosexual spread of HIV-2 than HIV-1. Lancet 343:943-946. http://dx.doi.org/10.1016/S0140-6736(94)90065-5.
3. Marlink R. 1996. Lessons from the second AIDS virus, HIV-2. AIDS. 10:689-699. (Pubitemid 26172771)
4. Whittle H, Morris J, Todd J, Corrah T, Sabally S, Bangali J, Ngom PT, Rolfe M, Wilkins A. 1994. HIV-2-infected patients survive longer than HIV-1-infected patients. AIDS 8:1617-1620. http://dx.doi.org/10.1097/00002030- 199411000-00015.
5. Desbois D, Roquebert B, Peytavin G, Damond F, Collin G, Benard A, Campa P, Matheron S, Chene G, Brun-Vezinet F, Descamps D. 2008. In vitro phenotypic susceptibility of human immunodeficiency virus type 2 clinical isolates to protease inhibitors. Antimicrob. Agents Chemother. 52:1545-1548. http://dx.doi.org/10.1128/AAC.01284-07. (Pubitemid 351522031)
6. Witvrouw M, Pannecouque C, Switzer WM, Folks TM, De Clercq E, Heneine W. 2004. Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis. Antivir. Ther. 9:57-65. (Pubitemid 38313948)
7. Marlink R, Kanki P, Thior I, Travers K, Eisen G, Siby T, Traore I, Hsieh CC, Dia MC, Gueye EH, Hellinger J, Gueye-Ndiaye A, Sankale JL, Ndoye I, Mboup S, Essex ME. 1994. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 265:1587-1590. http://dx.doi.org/10.1126/science. 7915856. (Pubitemid 24308975)
8. Matheron S, Mendoza-Sassi G, Simon F, Olivares R, Coulaud JP, Brun-Vezinet F. 1997. HIV-1 and HIV-2 AIDS in African patients living in Paris. AIDS 11:934-936. (Pubitemid 27226422)
9. Nunn AJ, Mulder DW, Kamali A, Ruberantwari A, Kengeya-Kayondo JF, Whitworth J. 1997. Mortality associated with HIV-1 infection over five years in a rural Ugandan population: cohort study. BMJ 315:767-771. http://dx.doi.org/10. 1136/bmj.315.7111.767. (Pubitemid 27405942)
10. Poulsen AG, Aaby P, Larsen O, Jensen H, Naucler A, Lisse IM, Christiansen CB, Dias F, Melbye M. 1997. 9-year HIV-2-associated mortality in an urban community in Bissau, west Africa. Lancet 349:911-914. http://dx.doi.org/10.1016/ S0140-6736(96)04402-9. (Pubitemid 27139820)
11. Smith NA, Shaw T, Berry N, Vella C, Okorafor L, Taylor D, Ainsworth J, Choudhury A, Daniels RS, El-Gadi S, Fakoya A, Moyle G, Oxford J, Tedder R, O'Shea S, de Ruiter A, Breuer J. 2001. Antiretroviral therapy for HIV-2-infected patients. J. Infect. 42:126-133. http://dx.doi.org/10.1053/jinf.2001.0792.
12. Chang M, Gottlieb GS, Dragavon JA, Cherne SL, Kenney DL, Hawes SE, Smith RA, Kiviat NB, Sow PS, Coombs RW. 2012. Validation for clinical use of a novel HIV-2 plasma RNA viral load assay using the Abbott m2000 platform. J. Clin. Virol. 55:128-133. http://dx.doi.org/10.1016/j.jcv.2012.06.024.
13. Damond F, Collin G, Descamps D, Matheron S, Pueyo S, Taieb A, Campa P, Benard A, Chene G, Brun-Vezinet F. 2005. Improved sensitivity of human immunodeficiency virus type 2 subtype B plasma viral load assay. J. Clin. Microbiol. 43:4234-4236. http://dx.doi.org/10.1128/JCM.43.8.4234-4236.2005. (Pubitemid 41129736)
14. Delarue S, Didier E, Damond F, Ponscarme D, Brengle-Pesce K, Resche-Rigon M, Vray M, Gueudin M, Simon F. 2013. Highly sensitive plasmaRNAquantification by real-time PCR in HIV-2 groupAand group B infection. J. Clin. Virol. 58:461-467. http://dx.doi.org/10.1016/j.jcv.2013.08.003.
15. Ferns RB, Garson JA. 2006. Development and evaluation of a real-time RT-PCR assay for quantification of cell-free human immunodeficiency virus type 2 using a Brome mosaic virus internal control. J. Virol. Methods 135:102-108. http://dx.doi.org/10.1016/j.jviromet.2006.02.005. (Pubitemid 43728849)
16. Rodes B, Sheldon J, Toro C, Cuevas L, Perez-Pastrana E, Herrera I, Soriano V. 2007. Quantitative detection of plasma human immunodeficiency virus type 2 subtypeARNAby the Nuclisens EasyQ Assay (version 1.1). J. Clin. Microbiol. 45:88-92. http://dx.doi.org/10.1128/JCM.01613-06. (Pubitemid 46106411)
17. Ruelle J, Mukadi BK, Schutten M, Goubau P. 2004. Quantitative real-time PCR on Lightcycler for the detection of human immunodeficiency virus type 2 (HIV-2). J. Virol. Methods 117:67-74. http://dx.doi.org/10.1016/j.jviromet.2003. 12.006. (Pubitemid 38281286)
18. Styer LM, Miller TT, Parker MM. 2013. Validation and clinical use of a sensitive HIV-2 viral load assay that uses a whole virus internal control. J. Clin. Virol. 58(Suppl 1):e127- e133.
19. 2E quality control study. J. Clin. Microbiol. 49:3491-3497. http://dx.doi.org/10.1128/JCM.02389-10.
20. Damond F, Benard A, Ruelle J, Alabi A, Kupfer B, Gomes P, Rodes B, Albert J, Boni J, Garson J, Ferns B, Matheron S, Chene G, Brun-Vezinet F. 2008. Quality control assessment of human immunodeficiency virus type 2 (HIV-2) viral load quantification assays: results from an international collaboration on HIV-2 infection in 2006. J. Clin. Microbiol. 46:2088-2091. http://dx.doi.org/10.1128/ JCM.00126-08. (Pubitemid 351831850)
21. Ayouba A, Akoua-Koffi C, Calvignac-Spencer S, Esteban A, Locatelli S, Li H, Li Y, Hahn BH, Delaporte E, Leendertz FH, Peeters M. 2013. Evidence for continuing cross-species transmission of SIVsmm to humans: characterization of a new HIV-2 lineage in rural Cote d'Ivoire. AIDS 27:2488-2491. http://dx.doi.org/10.1097/01.aids.0000432443.22684.50.
22. Damond F, Worobey M, Campa P, Farfara I, Collin G, Matheron S, Brun-Vezinet F, Robertson DL, Simon F. 2004. Identification of a highly divergent HIV-2 and proposal for a change in HIV-2 classification. AIDS Res. Hum. Retroviruses 20: 666-672. http://dx.doi.org/10.1089/0889222041217392. (Pubitemid 38813665)
23. Gao F, Yue L, Robertson DL, Hill SC, Hui H, Biggar RJ, Neequaye AE, Whelan TM, Ho DD, Shaw GM. 1994. Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology. J. Virol. 68:7433-7447. (Pubitemid 24328799)
24. Schulz TF, Whitby D, Hoad JG, Corrah T, Whittle H, Weiss RA. 1990. Biological and molecular variability of human immunodeficiency virus type 2 isolates from The Gambia. J. Virol. 64:5177-5182. (Pubitemid 20329844)
25. Soriano V, Gomes P, Heneine W, Holguin A, Doruana M, Antunes R, Mansinho K, Switzer WM, Araujo C, Shanmugam V, Lourenco H, Gonzalez-Lahoz J, Antunes F. 2000. Human immunodeficiency virus type 2 (HIV-2) in Portugal: clinical spectrum, circulating subtypes, virus isolation, and plasma viral load. J. Med. Virol. 61:111-116. (Pubitemid 30191235)
26. Aghokeng AF, Monleau M, Eymard-Duvernay S, Dagnra A, Kania D, Ngo-Giang-Huong N, Toni TD, Toure-Kane C, Truong LX, Delaporte E, Chaix ML, Peeters M, Ayouba A. 2013. Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health approach in Sub-Saharan Africa and Southeast Asia. Clin. Infect. Dis. 58:99-109. http://dx.doi.org/10.1093/cid/cit627.
27. Rouet F, Ekouevi DK, Chaix ML, Burgard M, Inwoley A, Tony TD, Danel C, Anglaret X, Leroy V, Msellati P, Dabis F, Rouzioux C. 2005. Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting. J. Clin. Microbiol. 43:2709-2717. http://dx.doi.org/10.1128/JCM.43.6.2709-2717.2005. (Pubitemid 40827943)
28. Rouet F, Ekouevi DK, Inwoley A, Chaix ML, Burgard M, Bequet L, Viho I, Leroy V, Simon F, Dabis F, Rouzioux C. 2004. Field evaluation of a rapid human immunodeficiency virus (HIV) serial serologic testing algorithm for diagnosis and differentiation of HIV type 1 (HIV-1), HIV-2, and dual HIV-1-HIV-2 infections in West African pregnant women. J. Clin. Microbiol. 42:4147-4153. http://dx.doi.org/10.1128/JCM.42.9.4147-4153.2004. (Pubitemid 39296137)
29. Bland JM, Altman DG. 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet i:307-310. (Pubitemid 16134762)
30. Plantier JC, Gueudin M, de Oliveira F, Damond F, Lemee V, Brun-Vezinet F, Simon F. 2004. Rapid discrimination between human immunodeficiency virus type 2 groups A and B by real-time PCR. J. Clin. Microbiol. 42:5866-5870. http://dx.doi.org/10.1128/JCM.42.12.5866-5870.2004. (Pubitemid 39664381)
31. Damond F, Avettand-Fenoel V, Collin G, Roquebert B, Plantier JC, Ganon A, Sizmann D, Babiel R, Glaubitz J, Chaix ML, Brun-Vezinet F, Descamps D, Rouzioux C. 2010. Evaluation of an upgraded version of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test for HIV-1 load quantification. J. Clin. Microbiol. 48:1413-1416. http://dx.doi.org/10.1128/JCM.01409-09.